Hydrogels For Peptide Hormones Delivery: Therapeutic And Tissue Engineering Applications

References

• Lau JL, Dunn MK. Therapeutic peptides: historical perspectives, current development trends, and future directions. Bioorg Med Chem. 2018;26(10):2700–2707. doi:10.1016/j.bmc.2017.06.05228720325
   PubMed Web of Science ®Google Scholar
• Frokjaer S, Otzen DE. Protein drug stability: a formulation challenge. Nat Rev Drug Discov. 2005;4(4):298. doi:10.1038/nrd187615803194
   PubMed Web of Science ®Google Scholar
• Verma M, Furin J, Langer R, Traverso G. Making the case: developing innovative adherence solutions for the treatment of tuberculosis. BMJ Global Health. 2019;4(1):e001323. doi:10.1136/bmjgh-2018-001323
   PubMed Web of Science ®Google Scholar
• Park K. Controlled drug delivery systems: past forward and future back. J Controlled Release. 2014;190:3–8. doi:10.1016/j.jconrel.2014.03.054
   PubMed Web of Science ®Google Scholar
• Deb PK, Al-Attraqchi O, Chandrasekaran B, Paradkar A, Tekade RK. Protein/peptide drug delivery systems: practical considerations in pharmaceutical product development In: Basic Fundamentals of Drug Delivery. Elsevier; 2019:651–684.
   Google Scholar
• Shaji J, Patole V. Protein and peptide drug delivery: oral approaches. Indian J Pharm Sci. 2008;70(3):269. doi:10.4103/0250-474X.4296720046732
   PubMed Web of Science ®Google Scholar
• El-Sherbiny I, Khalil I, Ali I, Yacoub M. Updates on smart polymeric carrier systems for protein delivery. Drug Dev Ind Pharm. 2017;43(10):1567–1583. doi:10.1080/03639045.2017.133872328581834
   PubMed Web of Science ®Google Scholar
• Ghasemi R, Abdollahi M, Zadeh EE, et al. mPEG-PLA and PLA-PEG-PLA nanoparticles as new carriers for delivery of recombinant human Growth Hormone (rhGH). Sci Rep. 2018;8(1):9854. doi:10.1038/s41598-018-28092-829959339
   PubMed Web of Science ®Google Scholar
• Nikolić LB, Zdravković AS, Nikolić VD, Ilić-Stojanović SS. Synthetic hydrogels and their impact on health and environment In: Cellulose-Based Superabsorbent Hydrogels. Berlin: Springer; 2018:1–29.
   Google Scholar
• Park YS, Lee Y, Jin YM, et al. Sustained release of parathyroid hormone via in situ cross‐linking gelatin hydrogels improves the therapeutic potential of tonsil‐derived mesenchymal stem cells for hypoparathyroidism. J Tissue Eng Regen Med. 2018;12(3):e1747–e1756. doi:10.1002/term.243028244684
   PubMed Web of Science ®Google Scholar
• Bandopadhyay S, Bandyopadhyay N, Deb PK, Singh C, Tekade RK. Preformulation studies of drug substances, protein, and peptides: role in drug discovery and pharmaceutical product development In: Dosage Form Design Considerations. Elsevier; 2018:401–433.
   Google Scholar
• Ahmed EM. Hydrogel: preparation, characterization, and applications: a review. J Adv Res. 2015;6(2):105–121. doi:10.1016/j.jare.2013.07.00625750745
   PubMed Web of Science ®Google Scholar
• Mohammadinejad R, Maleki H, Larrañeta E, et al. Status and future scope of plant-based green hydrogels in biomedical engineering. Appl Mater Today. 2019;16:213–246. doi:10.1016/j.apmt.2019.04.010
   Web of Science ®Google Scholar
• Du G, Peng Y, Pei Y, Zhao L, Wen Z, Hu Z. Thermo-responsive temporary plugging agent based on multiple phase transition supramolecular gel. Energy Fuels. 2017;31(9):9283–9289. doi:10.1021/acs.energyfuels.7b01691
   Web of Science ®Google Scholar
• Ullah F, Othman MBH, Javed F, Ahmad Z, Akil HM. Classification, processing and application of hydrogels: a review. Mater Sci Eng C. 2015;57:414–433. doi:10.1016/j.msec.2015.07.053
   PubMed Web of Science ®Google Scholar
• Tomar N, Tomar M, Gulati N, Nagaich U. pHEMA hydrogels: devices for ocular drug delivery. Int J Res Health Allied Sci. 2012;1(4):224. doi:10.4103/2278-344X.107844
   Google Scholar
• Peppas N, Bures P, Leobandung W, Ichikawa H. Hydrogels in pharmaceutical formulations. Eur J Pharm Biopharm. 2000;50(1):27–46.10840191
   PubMed Web of Science ®Google Scholar
• Norman AW, Litwack G. Hormones. Academic Press; 1997.
   Google Scholar
• Khpal M, Singer M. Inflammation, Hormones, and Metabolism In: Inflammation: From Molecular and Cellular Mechanisms to the Clinic. New York: John Wiley & Sons, Inc; 2017:915–946.
   Google Scholar
• Law S, Huang K, Chou V. Stability of desmopressin loaded in liposomes. J Liposome Res. 2003;13(3–4):269–277. doi:10.1081/LPR-12002639214670232
   PubMed Web of Science ®Google Scholar
• Gavrila A, Hollenberg AN. The hypothalamic-pituitary-thyroid axis: physiological regulation and clinical implications In: The Thyroid and Its Diseases. Springer; 2019:13–23.
   Google Scholar
• Parsons JA. Peptide Hormones. University Park Press; 1976.
   Google Scholar
• Avanti C. Innovative Strategies for Stabilization of Therapeutic Peptides in Aqueous Formulations. 2012.
   Google Scholar
• Varamini P, Toth I. Recent advances in oral delivery of peptide hormones. Expert Opin Drug Deliv. 2016;13(4):507–522. doi:10.1517/17425247.2016.114252626787260
   PubMed Web of Science ®Google Scholar
• Schulingkamp R, Pagano T, Hung D, Raffa R. Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci Biobehav Rev. 2000;24(8):855–872.11118610
   PubMed Web of Science ®Google Scholar
• Pawar VK, Meher JG, Singh Y, Chaurasia M, Reddy BS, Chourasia MK. Targeting of gastrointestinal tract for amended delivery of protein/peptide therapeutics: strategies and industrial perspectives. J Controlled Release. 2014;196:168–183. doi:10.1016/j.jconrel.2014.09.031
   PubMed Web of Science ®Google Scholar
• Dragan ES. Design and applications of interpenetrating polymer network hydrogels. A review. Chem Eng J. 2014;243:572–590. doi:10.1016/j.cej.2014.01.065
   Web of Science ®Google Scholar
• Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544–575. doi:10.1007/s11095-009-0045-620143256
   PubMed Web of Science ®Google Scholar
• Muheem A, Shakeel F, Jahangir MA, et al. A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives. Saudi Pharm J. 2016;24(4):413–428. doi:10.1016/j.jsps.2014.06.00427330372
   PubMed Web of Science ®Google Scholar
• Bruno BJ, Miller GD, Lim CS. Basics and recent advances in peptide and protein drug delivery. Ther Deliv. 2013;4(11):1443–1467. doi:10.4155/tde.13.10424228993
   PubMedGoogle Scholar
• Tan ML, Choong PF, Dass CR. Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery. Peptides. 2010;31(1):184–193. doi:10.1016/j.peptides.2009.10.00219819278
   PubMed Web of Science ®Google Scholar
• Cholewinski M, Lückel B, Horn H. Degradation pathways, analytical characterization and formulation strategies of a peptide and a protein calcitonine and human growth hormone in comparison. Pharm Acta Helv. 1996;71(6):405–419.8997176
   PubMedGoogle Scholar
• Chaturvedi K, Ganguly K, Nadagouda MN, Aminabhavi TM. Polymeric hydrogels for oral insulin delivery. J Controlled Release. 2013;165(2):129–138. doi:10.1016/j.jconrel.2012.11.005
   PubMed Web of Science ®Google Scholar
• Zelikin AN, Ehrhardt C, Healy AM. Materials and methods for delivery of biological drugs. Nat Chem. 2016;8(11):997. doi:10.1038/nchem.262927768097
   PubMed Web of Science ®Google Scholar
• Sarmento B, Ribeiro A, Veiga F, Ferreira D, Neufeld R. Oral bioavailability of insulin contained in polysaccharide nanoparticles. Biomacromolecules. 2007;8(10):3054–3060. doi:10.1021/bm070392317877397
   PubMed Web of Science ®Google Scholar
• Martinho N, Damgé C, Reis CP. Recent advances in drug delivery systems. J Biomater Nanobiotechnol. 2011;2(05):510. doi:10.4236/jbnb.2011.225062
   Google Scholar
• Niu Z, Conejos-Sanchez I, Griffin BT, O’Driscoll CM, Alonso MJ. Lipid-based nanocarriers for oral peptide delivery. Adv Drug Del Rev. 2016;106:337–354. doi:10.1016/j.addr.2016.04.001
   PubMed Web of Science ®Google Scholar
• Carino GP, Jacob JS, Mathiowitz E. Nanosphere based oral insulin delivery. J Controlled Release. 2000;65(1–2):261–269. doi:10.1016/S0168-3659(99)00247-3
   PubMed Web of Science ®Google Scholar
• Khafagy E-S, Morishita M, Onuki Y, Takayama K. Current challenges in non-invasive insulin delivery systems: a comparative review. Adv Drug Del Rev. 2007;59(15):1521–1546. doi:10.1016/j.addr.2007.08.019
   PubMed Web of Science ®Google Scholar
• Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharm. 1999;185(2):129–188.10460913
   PubMed Web of Science ®Google Scholar
• Savale SK. Protein and peptide drug delivery system. World J Pharm Pharm Sci. 2016;5(4):1–19.
   Google Scholar
• Clement S, Still JG, Kosutic G, McAllister R. Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2. Diabetes Technol Ther. 2002;4(4):459–466. doi:10.1089/15209150276030654412396740
   PubMedGoogle Scholar
• Ismail R, Csoka I. Novel strategies in the oral delivery of antidiabetic peptide drugs – insulin, GLP 1 and its analogs. Eur J Pharm Biopharm. 2017;115:257–267. doi:10.1016/j.ejpb.2017.03.01528336368
   PubMed Web of Science ®Google Scholar
• Hirakura T, Yasugi K, Nemoto T, et al. Hybrid hyaluronan hydrogel encapsulating nanogel as a protein nanocarrier: new system for sustained delivery of protein with a chaperone-like function. J Control Release. 2010;142(3):483–489. doi:10.1016/j.jconrel.2009.11.02319951730
   PubMed Web of Science ®Google Scholar
• Pasut G, Veronese FM. State of the art in PEGylation: the great versatility achieved after forty years of research. J Controlled Release. 2012;161(2):461–472. doi:10.1016/j.jconrel.2011.10.037
   PubMed Web of Science ®Google Scholar
• Batrakovaa EV, Kabanov AV. Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Controlled Release. 2008;130(2):98–106. doi:10.1016/j.jconrel.2008.04.013
   PubMed Web of Science ®Google Scholar
• Suthiwangcharoen N, Nagarajan R. Nanoarmoring of proteins by conjugation to block copolymer micelles. Methods Enzymol. 2017;590(Elsevier):277–304. doi:10.1016/bs.mie.2017.01.01328411641
   PubMed Web of Science ®Google Scholar
• Labonté V, Marion A, Virgilio N, Tavares JR. Gas-phase surface engineering of polystyrene beads used to challenge automated particle inspection systems. Ind Eng Chem Res. 2016;55(27):7362–7372. doi:10.1021/acs.iecr.6b01573
   Web of Science ®Google Scholar
• Swaminathan J. C. E. Liposomal delivery of proteins and peptides. Expert Opin Drug Deliv. 2012;9(12):1489–1503. doi:10.1517/17425247.2012.73565823092138
   PubMed Web of Science ®Google Scholar
• Li X, Kuromi H, Briggs L, et al. Bicaudal-D binds clathrin heavy chain to promote its transport and augments synaptic vesicle recycling. Embo J. 2010;29(5):992–1006. doi:10.1038/emboj.2009.41020111007
   PubMed Web of Science ®Google Scholar
• Kaur G, Garg T, Rath G, Goyal AK. Archaeosomes: an excellent carrier for drug and cell delivery. Drug Deliv. 2016;23(7):2497–2512. doi:10.3109/10717544.2015.101965325777339
   PubMed Web of Science ®Google Scholar
• Mohanraj VJ, Barnes TJ, Prestidge CA. Silica nanoparticle coated liposomes: a new type of hybrid nanocapsule for proteins. Int J Pharm. 2010;392(1–2):285–293. doi:10.1016/j.ijpharm.2010.03.06120363300
   PubMed Web of Science ®Google Scholar
• Dombu CY, Betbeder D. Airway delivery of peptides and proteins using nanoparticles. Biomaterials. 2013;34(2):516–525. doi:10.1016/j.biomaterials.2012.08.07023046753
   PubMed Web of Science ®Google Scholar
• Fröhlich E. Value of phagocyte function screening for immunotoxicity of nanoparticles in vivo. Int J Nanomedicine. 2015;10:3761–3778. doi:10.2147/IJN.S8306826060398
   PubMed Web of Science ®Google Scholar
• Amancha PK, Balkundi S, Lvov Y, et al. Pulmonary sustained release of insulin from microparticles composed of polyelectrolyte layer-by-layer assembly. Int J Pharm. 2014;466(1–2):96–108. doi:10.1016/j.ijpharm.2014.02.00624566038
   PubMed Web of Science ®Google Scholar
• Andrade A, Rossi RC, Stival VP, et al. Different supplements for finishing of Nellore cattle on deferred Brachiaria decumbens pasture during the dry season. Bol Ind Anim. 2015;72(2):91–101. doi:10.17523/bia.v72n2p91
   Google Scholar
• Jafari G, Wasko BM, Tonge A, et al. Tether mutations that restore function and suppress pleiotropic phenotypes of the C. elegans isp-1(qm150) Rieske iron–sulfur protein. Pnas. 2015;112(45):E6148–E6157. doi:10.1073/pnas.150941611226504246
   PubMed Web of Science ®Google Scholar
• Teleanu DM, Negut I, Grumezescu V, Grumezescu AM, Teleanu RI. Nanomaterials for drug delivery to the central nervous system. Nanomaterials. 2019;9(3):371. doi:10.3390/nano9071000
   Web of Science ®Google Scholar
• Pawar R, Ben-Ari A, Domb AJ. Protein and peptide parenteral controlled delivery. Expert Opin Biol Ther. 2004;4(8):1203–1212. doi:10.1517/14712598.4.8.120315268656
   PubMed Web of Science ®Google Scholar
• Hutchinson J, Burholt S, Hamley I. Peptide hormones and lipopeptides: from self‐assembly to therapeutic applications. J Pept Sci. 2017;23(2):82–94. doi:10.1002/psc.295428127868
   PubMed Web of Science ®Google Scholar
• Parhi R. Cross-linked hydrogel for pharmaceutical applications: a review. Adv Pharm Bull. 2017;7(4):515–530. doi:10.15171/apb.2017.06429399542
   PubMed Web of Science ®Google Scholar
• Hoffman AS. Hydrogels for biomedical applications. Adv Drug Deliv Rev. 2012;64:18–23. doi:10.1016/j.addr.2012.09.010
   Web of Science ®Google Scholar
• Phan VG, Thambi T, Duong HTT, Lee DS. Poly (amino carbonate urethane)-based biodegradable, temperature and pH-sensitive injectable hydrogels for sustained human growth hormone delivery. Sci Rep. 2016;6:29978. doi:10.1038/srep2997827436576
   PubMed Web of Science ®Google Scholar
• Schoener CA, Hutson HN, Peppas NA. pH‐responsive hydrogels with dispersed hydrophobic nanoparticles for the delivery of hydrophobic therapeutic agents. Polym Int. 2012;61(6):874–879. doi:10.1002/pi.421923087546
   PubMed Web of Science ®Google Scholar
• Batista RA, Otoni CG, Espitia PJ. Fundamentals of chitosan-based hydrogels: elaboration and characterization techniques In: Materials for Biomedical Engineering. Elsevier; 2019:61–81.
   Google Scholar
• Los E, Rosenfeld RG Growth and growth hormone in turner syndrome: looking back, looking ahead. Paper presented at: American Journal of Medical Genetics Part C: Seminars in Medical Genetics; 2019.
   Google Scholar
• Dao LN, Lippe B, Laird M, Beierle I. Human growth hormone In: Pharmaceutical Biotechnology. Springer; 2019:437–449.
   Google Scholar
• Amato G, Mazziotti G, Di Somma C, et al. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections. J Clin Endocrinol Metab. 2000;85(10):3720–3725. doi:10.1210/jcem.85.10.688111061530
   PubMed Web of Science ®Google Scholar
• Cai Y, Xu M, Yuan M, Liu Z, Yuan W. Developments in human growth hormone preparations: sustained-release, prolonged half-life, novel injection devices, and alternative delivery routes. Int J Nanomedicine. 2014;9:3527.25114523
   PubMed Web of Science ®Google Scholar
• Webster R, Xie R, Didier E, et al. PEGylation of somatropin (recombinant human growth hormone): impact on its clearance in humans. Xenobiotica. 2008;38(10):1340–1351. doi:10.1080/0049825080241385618802875
   PubMed Web of Science ®Google Scholar
• Goto T, Morishita M, Kavimandan NJ, Takayama K, Peppas NA. Gastrointestinal transit and mucoadhesive characteristics of complexation hydrogels in rats. J Pharm Sci. 2006;95(2):462–469. doi:10.1002/jps.2056616381013
   PubMed Web of Science ®Google Scholar
• López JE, Peppas NA. Effect of poly (ethylene glycol) molecular weight and microparticle size on oral insulin delivery from P (MAA‐g‐EG) Microparticles. Drug Dev Ind Pharm. 2004;30(5):497–504. doi:10.1081/DDC-12003748015244085
   PubMed Web of Science ®Google Scholar
• Atayde EC Jr, Montalbo RCK, Arco SD. Temperature-and pH-dependent drug release of block copolymers of methacrylic acid and poly (ethylene glycol) methyl ether methacrylates. Philipp J Sci. 2018;147(3):363–372.
   Google Scholar
• Atayde EC Jr, Montalbo RCK, Arco SD Linear and hyperbranched copolymers of PEG-based acrylates and methacrylic acid as ph-responsive hydrophobic drug carriers. Paper presented at: Materials Science Forum; 2018.
   Google Scholar
• Carr DA, Peppas NA. Assessment of poly (methacrylic acid‐co‐N‐vinyl pyrrolidone) as a carrier for the oral delivery of therapeutic proteins using Caco‐2 and HT29‐MTX cell lines. J Biomed Mater Res Part A. 2010;92(2):504–512.
   PubMedGoogle Scholar
• Cascone MG, Di Silvio L, Sim B, Downes S. Collagen and hyaluronic acid based polymeric blends as drug delivery systems for the release of physiological concentrations of growth hormone. Jmsmm. 1994;5(9–10):770–774.
   Google Scholar
• Veldhuis JD. A tripeptidyl ensemble perspective of interactive control of growth hormone secretion. Horm Res Paediatr. 2003;60(Suppl. 1):86–101. doi:10.1159/000071232
   Web of Science ®Google Scholar
• Okumu FW, Dao LN, Fielder PJ, et al. Sustained delivery of human growth hormone from a novel gel system: SABERTM. Biomaterials. 2002;23(22):4353–4358. doi:10.1016/s0142-9612(02)00174-612219825
   PubMed Web of Science ®Google Scholar
• Tae G, Lammertink RG, Kornfield JA, Hubbell JA. Facile hydrophilic surface modification of poly (tetrafluoroethylene) using fluoroalkyl‐terminated poly (ethylene glycol)s. Adv Mater. 2003;15(1):66–69. doi:10.1002/(ISSN)1521-4095
   Web of Science ®Google Scholar
• Burdick JA, Anseth KS. Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering. Biomaterials. 2002;23(22):4315–4323. doi:10.1016/s0142-9612(02)00176-x12219821
   PubMed Web of Science ®Google Scholar
• Nir Y, Paz A, Sabo E, Potasman I. Fear of injections in young adults: prevalence and associations. Am J Trop Med Hyg. 2003;68(3):341–344.12685642
   PubMed Web of Science ®Google Scholar
• Liu L, Yang H, Lou Y, et al. Enhancement of oral bioavailability of salmon calcitonin through chitosan-modified, dual drug-loaded nanoparticles. Int J Pharm. 2019;557:170–177. doi:10.1016/j.ijpharm.2018.12.05330597264
   PubMed Web of Science ®Google Scholar
• Li N, Li X-R, Zhou Y-X, et al. The use of polyion complex micelles to enhance the oral delivery of salmon calcitonin and transport mechanism across the intestinal epithelial barrier. Biomaterials. 2012;33(34):8881–8892. doi:10.1016/j.biomaterials.2012.08.04722975427
   PubMed Web of Science ®Google Scholar
• Torres-Lugo M, Peppas NA. Molecular design and in vitro studies of novel pH-sensitive hydrogels for the oral delivery of calcitonin. Macromolecules. 1999;32(20):6646–6651. doi:10.1021/ma990541c
   Web of Science ®Google Scholar
• Donini C, Robinson D, Colombo P, Giordano F, Peppas N. Preparation of poly (methacrylic acid-g-poly (ethylene glycol)) nanospheres from methacrylic monomers for pharmaceutical applications. Int J Pharm. 2002;245(1–2):83–91.12270245
   PubMed Web of Science ®Google Scholar
• Kamei N, Morishita M, Chiba H, Kavimandan NJ, Peppas NA, Takayama K. Complexation hydrogels for intestinal delivery of interferon β and calcitonin. J Controlled Release. 2009;134(2):98–102. doi:10.1016/j.jconrel.2008.11.014
   PubMed Web of Science ®Google Scholar
• Owens DR, Zinman B, Bolli G. Alternative routes of insulin delivery. Diabet Med. 2003;20(11):886–898. doi:10.1046/j.1464-5491.2003.01076.x14632713
   PubMed Web of Science ®Google Scholar
• Bahman F, Greish K, Taurin S. Nanotechnology in insulin delivery for management of diabetes. Pharmaceutical Nanotechnology. 2019;7:113–128. doi:10.2174/221173850766619032111072130907328
   PubMedGoogle Scholar
• Gordon Still J. Development of oral insulin: progress and current status. Diabetes Metab Res Rev. 2002;18:S1. doi:10.1002/dmrr.207
   Web of Science ®Google Scholar
• Li J, Wang Y, Han L, Sun X, Yu H, Yu Y. Time–action profile of an oral enteric insulin formulation in healthy Chinese volunteers. Clin Ther. 2012;34(12):2333–2338. doi:10.1016/j.clinthera.2012.11.00423195963
   PubMed Web of Science ®Google Scholar
• Morales-Burgos AM, Carvajal-Millan E, Sotelo-Cruz N, et al. Polysaccharides in alternative methods for insulin delivery In Biopolymer Grafting. Elsevier; 2018:175–197.
   Google Scholar
• Morishita M, Lowman AM, Takayama K, Nagai T, Peppas NA. Elucidation of the mechanism of incorporation of insulin in controlled release systems based on complexation polymers. J Controlled Release. 2002;81(1):25–32. doi:10.1016/S0168-3659(02)00019-6
   PubMed Web of Science ®Google Scholar
• Morishita M, Goto T, Peppas NA, et al. Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption. J Controlled Release. 2004;97(1):115–124. doi:10.1016/j.jconrel.2004.03.008
   PubMed Web of Science ®Google Scholar
• Foss AC, Peppas NA. Investigation of the cytotoxicity and insulin transport of acrylic-based copolymer protein delivery systems in contact with Caco-2 cultures. Eur J Pharm Biopharm. 2004;57(3):447–455. doi:10.1016/j.ejpb.2004.02.00815093592
   PubMed Web of Science ®Google Scholar
• Fukuoka Y, Khafagy E-S, Goto T, et al. Combination strategy with complexation hydrogels and cell-penetrating peptides for oral delivery of insulin. Biol Pharm Bull. 2018;41(5):811–814. doi:10.1248/bpb.b17-0095129709919
   PubMed Web of Science ®Google Scholar
• Sonaje K, Chen Y-J, Chen H-L, et al. Enteric-coated capsules filled with freeze-dried chitosan/poly (γ-glutamic acid) nanoparticles for oral insulin delivery. Biomaterials. 2010;31(12):3384–3394. doi:10.1016/j.biomaterials.2010.01.04220149435
   PubMed Web of Science ®Google Scholar
• Dorkoosh F, Verhoef JC, Borchard G, Rafiee-Tehrani M, Verheijden J, Junginger H. Intestinal absorption of human insulin in pigs using delivery systems based on superporous hydrogel polymers. Int J Pharm. 2002;247(1):47–55.12429484
   PubMed Web of Science ®Google Scholar
• Nguyen MK, Lee DS. Controlling the degradation of pH/temperature-sensitive injectable hydrogels based on poly (β-amino ester). Macromolecular Research. 2010;18(2):192–199. doi:10.1007/s13233-009-0182-0
   Web of Science ®Google Scholar
• Rasool N, Yasin T, Heng JY, Akhter Z. Synthesis and characterization of novel pH-, ionic strength and temperature-sensitive hydrogel for insulin delivery. Poly. 2010;51(8):1687–1693. doi:10.1016/j.polymer.2010.02.013
   Web of Science ®Google Scholar
• Vermonden T, Censi R, Hennink WE. Hydrogels for protein delivery. Chem Rev. 2012;112(5):2853–2888. doi:10.1021/cr200157d22360637
   PubMed Web of Science ®Google Scholar
• James HP, John R, Alex A, Anoop K. Smart polymers for the controlled delivery of drugs–a concise overview. Acta Pharm Sin B. 2014;4(2):120–127. doi:10.1016/j.apsb.2014.02.00526579373
   PubMed Web of Science ®Google Scholar
• Patel A, Patel M, Yang X, K Mitra A. Recent advances in protein and peptide drug delivery: a special emphasis on polymeric nanoparticles. Protein Pept Lett. 2014;21(11):1102–1120.25106908
   PubMed Web of Science ®Google Scholar
• Rastogi R, Anand S, Koul V. Evaluation of pharmacological efficacy of ‘insulin–surfoplex’ encapsulated polymer vesicles. Int J Pharm. 2009;373(1):107–115. doi:10.1016/j.ijpharm.2009.01.02219429295
   PubMed Web of Science ®Google Scholar
• Elvassore N, Bertucco A, Caliceti P. Production of insulin‐loaded poly (ethylene glycol)/poly (l‐lactide)(PEG/PLA) nanoparticles by gas antisolvent techniques. J Pharm Sci. 2001;90(10):1628–1636. doi:10.1002/jps.111311745721
   PubMed Web of Science ®Google Scholar
• Reis CP, Veiga FJ, Ribeiro AJ, Neufeld RJ, Damgé C. Nanoparticulate biopolymers deliver insulin orally eliciting pharmacological response. J Pharm Sci. 2008;97(12):5290–5305. doi:10.1002/jps.2134718384153
   PubMed Web of Science ®Google Scholar
• Teijeiro-Osorio D, Remuñán-López C, Alonso MJ. New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules. Biomacromolecules. 2008;10(2):243–249. doi:10.1021/bm800975j
   Web of Science ®Google Scholar
• Al-Qadi S, Grenha A, Carrión-Recio D, Seijo B, Remuñán-López C. Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations. J Controlled Release. 2012;157(3):383–390. doi:10.1016/j.jconrel.2011.08.008
   PubMed Web of Science ®Google Scholar
• Fleige E, Quadir MA, Haag R. Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. Adv Drug Del Rev. 2012;64(9):866–884. doi:10.1016/j.addr.2012.01.020
   PubMed Web of Science ®Google Scholar
• Uchida T, Toida Y, Sakakibara S, et al. Preparation and characterization of insulin-loaded acrylic hydrogels containing absorption enhancers. Chem Pharm Bull (Tokyo). 2001;49(10):1261–1266. doi:10.1248/cpb.49.126111605651
   PubMed Web of Science ®Google Scholar
• Eng J, Kleinman W, Singh L, Singh G, Raufman J-P. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem. 1992;267(11):7402–7405.1313797
   PubMed Web of Science ®Google Scholar
• Nielsen LL, Young AA, Parkes DG. Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes. Regul Pept. 2004;117(2):77–88. doi:10.1016/j.regpep.2003.10.02814700743
   PubMedGoogle Scholar
• Ionut V, Zheng D, Stefanovski D, Bergman RN. Exenatide can reduce glucose independent of islet hormones or gastric emptying. Am J Physiol Endocrinol Metab. 2008;295(2):E269–E277. doi:10.1152/ajpendo.90222.200818492781
   PubMed Web of Science ®Google Scholar
• DeYoung MB, MacConell L, Sarin V, Trautmann M, Herbert P. Encapsulation of exenatide in poly-(D, L-lactide-co-glycolide) microspheres produced an investigational long-acting once-weekly formulation for type 2 diabetes. Diabetes Technol Ther. 2011;13(11):1145–1154. doi:10.1089/dia.2011.005021751887
   PubMed Web of Science ®Google Scholar
• Bae SJ, Suh JM, Sohn YS, Bae YH, Kim SW, Jeong B. Thermogelling poly (caprolactone-b-ethylene glycol-b-caprolactone) aqueous solutions. Macromolecules. 2005;38(12):5260–5265. doi:10.1021/ma050489m
   Web of Science ®Google Scholar
• Zhang Z, Ni J, Chen L, Yu L, Xu J, Ding J. Biodegradable and thermoreversible PCLA–PEG–PCLA hydrogel as a barrier for prevention of post-operative adhesion. Biomaterials. 2011;32(21):4725–4736. doi:10.1016/j.biomaterials.2011.03.04621482434
   PubMed Web of Science ®Google Scholar
• Li K, Yu L, Liu X, Chen C, Chen Q, Ding J. A long-acting formulation of a polypeptide drug exenatide in treatment of diabetes using an injectable block copolymer hydrogel. Biomaterials. 2013;34(11):2834–2842. doi:10.1016/j.biomaterials.2013.01.01323352120
   PubMed Web of Science ®Google Scholar
• Seo B-B, Park M-R, Chun C, Lee J-Y, Song S-C. The biological efficiency and bioavailability of human growth hormone delivered using injectable, ionic, thermosensitive poly (organophosphazene)-polyethylenimine conjugate hydrogels. Biomaterials. 2011;32(32):8271–8280. doi:10.1016/j.biomaterials.2011.07.03321839508
   PubMed Web of Science ®Google Scholar
• Seo B-B, Park M-R, Song S-C. Sustained release of exendin 4 using injectable and ionic-nano-complex forming polymer hydrogel system for long-term treatment of type 2 diabetes mellitus. ACS Appl Mater Interfaces. 2019;11(17):15201–15211. doi:10.1021/acsami.8b1966930945843
   PubMed Web of Science ®Google Scholar
• Chen Y, Luan J, Shen W, Lei K, Yu L, Ding J. Injectable and thermosensitive hydrogel containing liraglutide as a long-acting antidiabetic system. ACS Appl Mater Interfaces. 2016;8(45):30703–30713. doi:10.1021/acsami.6b0941527786459
   PubMed Web of Science ®Google Scholar
• Naahidi S, Jafari M, Logan M, et al. Biocompatibility of hydrogel-based scaffolds for tissue engineering applications. Biotechnol Adv. 2017;35(5):530–544. doi:10.1016/j.biotechadv.2017.05.00628558979
   PubMed Web of Science ®Google Scholar
• Eslahi N, Abdorahim M, Simchi A. Smart polymeric hydrogels for cartilage tissue engineering: a review on the chemistry and biological functions. Biomacromolecules. 2016;17(11):3441–3463. doi:10.1021/acs.biomac.6b0123527775329
   PubMed Web of Science ®Google Scholar
• Sood N, Bhardwaj A, Mehta S, Mehta A. Stimuli-responsive hydrogels in drug delivery and tissue engineering. Drug Deliv. 2016;23(3):748–770. doi:10.3109/10717544.2014.940091
   Web of Science ®Google Scholar
• Naot D, Musson DS, Cornish J. The activity of peptides of the calcitonin family in bone. Physiol Rev. 2018;99(1):781–805. doi:10.1152/physrev.00066.2017
   Web of Science ®Google Scholar
• Liu Y, Chen X, Li S, et al. Calcitonin-loaded thermosensitive hydrogel for long-term antiosteopenia therapy. ACS Appl Mater Interfaces. 2017;9(28):23428–23440. doi:10.1021/acsami.7b0574028640588
   PubMed Web of Science ®Google Scholar
• Pettway GJ, Meganck JA, Koh AJ, Keller ET, Goldstein SA, McCauley LK. Parathyroid hormone mediates bone growth through the regulation of osteoblast proliferation and differentiation. Bone. 2008;42(4):806–818. doi:10.1016/j.bone.2007.11.01718234576
   PubMed Web of Science ®Google Scholar
• Rowshan HH, Parham MA, Baur DA, et al. Effect of intermittent systemic administration of recombinant parathyroid hormone (1-34) on mandibular fracture healing in rats. JOMS. 2010;68(2):260–267.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang Y, Dai X, et al. Effects of intermittent administration of parathyroid hormone (1-34) on bone differentiation in stromal precursor antigen-1 positive human periodontal ligament stem cells In: Stem Cells International. 2016:2016.
   Google Scholar
• Ardura JA, Portal‐Núñez S, Lozano D, et al. Local delivery of parathyroid hormone‐related protein‐derived peptides coated onto a hydroxyapatite‐based implant enhances bone regeneration in old and diabetic rats. J Biomed Mater Res Part A. 2016;104(8):2060–2070. doi:10.1002/jbm.a.35742
   PubMed Web of Science ®Google Scholar